Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Journal of Medicinal Chemistry
|
December 4, 2003
Molecular model of the alpha(IIb)beta(3) integrin
Bradley P Feuston, J Christopher Culberson, George D Hartman
Journal of Chemical Information and Computer Sciences
|
November 24, 2004
Similarity to molecules in the training set is a good discriminator for prediction accuracy in QSAR
Robert P Sheridan, Bradley P Feuston, Vladimir N Maiorov, et al.
Journal of Chemical Information and Computer Sciences
|
November 25, 2003
Random forest: a classification and regression tool for compound classification and QSAR modeling
Vladimir Svetnik, Andy Liaw, Christopher Tong, et al.
Molecular Diversity
|
September 28, 2006
Scoring of KDR kinase inhibitors: using interaction energy as a guide for ranking
Georgia B McGaughey, J Chris Culberson, Bradley P Feuston, et al.
Journal of Medicinal Chemistry
|
December 13, 2002
Binding model for nonpeptide antagonists of alpha(v)beta(3) integrin
Bradley P Feuston, J Chris Culberson, Mark E Duggan, et al.
Biotechnology Progress
|
December 9, 2014
Targeted purification development enabled by computational biophysical modeling
Francis K Insaidoo, Michael A Rauscher, Shepard J Smithline, et al.
Journal of Chemical Information and Modeling
|
September 27, 2005
Reagent Selector: using Synthon Analysis to visualize reagent properties and assist in combinatorial library design
Ralph T Mosley, J Christopher Culberson, Bryan Kraker, et al.
Bioconjugate Chemistry
|
January 18, 2014
Molecular umbrella conjugate for the ocular delivery of siRNA
Vaclav Janout, Lauren L Cline, Bradley P Feuston, et al.
Current Topics in Medicinal Chemistry
|
August 17, 2005
Web enabling technology for the design, enumeration, optimization and tracking of compound libraries
Bradley P Feuston, Subhas J Chakravorty, John F Conway, et al.
Journal of Medicinal Chemistry
|
September 17, 2004
Nonpeptide alphavbeta3 antagonists. Part 11: discovery and preclinical evaluation of potent alphavbeta3 antagonists for the prevention and treatment of osteoporosis
Paul J Coleman, Karen M Brashear, Ben C Askew, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Journal of Medicinal Chemistry
|
December 4, 2003
Molecular model of the alpha(IIb)beta(3) integrin
Bradley P Feuston, J Christopher Culberson, George D Hartman
Journal of Chemical Information and Computer Sciences
|
November 24, 2004
Similarity to molecules in the training set is a good discriminator for prediction accuracy in QSAR
Robert P Sheridan, Bradley P Feuston, Vladimir N Maiorov, et al.
Journal of Chemical Information and Computer Sciences
|
November 25, 2003
Random forest: a classification and regression tool for compound classification and QSAR modeling
Vladimir Svetnik, Andy Liaw, Christopher Tong, et al.
Molecular Diversity
|
September 28, 2006
Scoring of KDR kinase inhibitors: using interaction energy as a guide for ranking
Georgia B McGaughey, J Chris Culberson, Bradley P Feuston, et al.
Journal of Medicinal Chemistry
|
December 13, 2002
Binding model for nonpeptide antagonists of alpha(v)beta(3) integrin
Bradley P Feuston, J Chris Culberson, Mark E Duggan, et al.
Biotechnology Progress
|
December 9, 2014
Targeted purification development enabled by computational biophysical modeling
Francis K Insaidoo, Michael A Rauscher, Shepard J Smithline, et al.
Journal of Chemical Information and Modeling
|
September 27, 2005
Reagent Selector: using Synthon Analysis to visualize reagent properties and assist in combinatorial library design
Ralph T Mosley, J Christopher Culberson, Bryan Kraker, et al.
Bioconjugate Chemistry
|
January 18, 2014
Molecular umbrella conjugate for the ocular delivery of siRNA
Vaclav Janout, Lauren L Cline, Bradley P Feuston, et al.
Current Topics in Medicinal Chemistry
|
August 17, 2005
Web enabling technology for the design, enumeration, optimization and tracking of compound libraries
Bradley P Feuston, Subhas J Chakravorty, John F Conway, et al.
Journal of Medicinal Chemistry
|
September 17, 2004
Nonpeptide alphavbeta3 antagonists. Part 11: discovery and preclinical evaluation of potent alphavbeta3 antagonists for the prevention and treatment of osteoporosis
Paul J Coleman, Karen M Brashear, Ben C Askew, et al.
Page
of 2